Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of TDRP mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TDRP mRNA | CTD | PMID:32109520 and PMID:33387578 | 2-hydroxypropanoic acid | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TDRP mRNA | CTD | PMID:30851411 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of TDRP gene | CTD | PMID:31601247 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Tdrp (Mus musculus) | 6480464 | Fenretinide results in decreased expression of TDRP mRNA | CTD | PMID:28973697 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of TDRP mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of TDRP mRNA | CTD | PMID:23630614 and PMID:25378103 | aflatoxin B1 | increases methylation | ISO | TDRP (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of TDRP polyA tail | CTD | PMID:30157460 | Aflatoxin B2 alpha | decreases methylation | ISO | TDRP (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of TDRP polyA tail | CTD | PMID:30157460 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of TDRP gene | CTD | PMID:35440735 | benzo[a]pyrene | multiple interactions | ISO | Tdrp (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TDRP mRNA | CTD | PMID:27858113 | benzo[a]pyrene | affects methylation | ISO | TDRP (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of TDRP polyA tail | CTD | PMID:30157460 | benzo[b]fluoranthene | increases expression | ISO | Tdrp (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of TDRP mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | Tdrp (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TDRP mRNA | CTD | PMID:27858113 | Benzo[ghi]perylene | increases expression | ISO | Tdrp (Mus musculus) | 6480464 | 1 and 12-benzoperylene results in increased expression of TDRP mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | ISO | Tdrp (Mus musculus) | 6480464 | bisphenol A results in decreased expression of TDRP mRNA | CTD | PMID:26063408 and PMID:33221593 | bisphenol A | increases methylation | ISO | TDRP (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of TDRP gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of TDRP gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TDRP mRNA | CTD | PMID:30816183 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TDRP mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol F | increases expression | ISO | Tdrp (Mus musculus) | 6480464 | bisphenol F results in increased expression of TDRP mRNA | CTD | PMID:30951980 | carmustine | affects response to substance | ISO | TDRP (Homo sapiens) | 6480464 | TDRP mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | chlorpyrifos | affects expression | ISO | Tdrp (Mus musculus) | 6480464 | Chlorpyrifos affects the expression of TDRP mRNA | CTD | PMID:37019170 | chrysene | multiple interactions | ISO | Tdrp (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TDRP mRNA | CTD | PMID:27858113 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of TDRP mRNA | CTD | PMID:24386269 | dichloroacetic acid | increases expression | ISO | Tdrp (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of TDRP mRNA | CTD | PMID:28962523 | dicrotophos | decreases expression | ISO | TDRP (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of TDRP mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of TDRP mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | entinostat results in increased expression of TDRP mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA | CTD | PMID:27188386 | fulvestrant | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of TDRP gene and [bisphenol S co-treated with Fulvestrant] results in decreased methylation of TDRP gene | CTD | PMID:31601247 | malathion | decreases expression | ISO | TDRP (Homo sapiens) | 6480464 | Malathion results in decreased expression of TDRP mRNA | CTD | PMID:37047231 | mercury dibromide | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of TDRP mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA | CTD | PMID:27188386 | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of TDRP mRNA | CTD | PMID:19564919 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of TDRP gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | TDRP (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of TDRP mRNA | CTD | PMID:23179753 and PMID:27188386 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | Tdrp (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TDRP mRNA | CTD | PMID:25566086 | nickel atom | decreases expression | ISO | TDRP (Homo sapiens) | 6480464 | Nickel results in decreased expression of TDRP mRNA | CTD | PMID:24768652 and PMID:25583101 | niclosamide | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | Niclosamide results in increased expression of TDRP mRNA | CTD | PMID:36318118 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TDRP mRNA | CTD | PMID:25729387 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of TDRP mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Tdrp (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TDRP mRNA | CTD | PMID:34911549 | panobinostat | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | panobinostat results in increased expression of TDRP mRNA | CTD | PMID:26272509 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of TDRP mRNA | CTD | PMID:33387578 | perfluorohexanesulfonic acid | decreases expression | ISO | Tdrp (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of TDRP mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Tdrp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TDRP mRNA | CTD | PMID:36331819 | phenylmercury acetate | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of TDRP mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA | CTD | PMID:27188386 | rac-lactic acid | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of TDRP mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of TDRP mRNA | CTD | PMID:34032870 | sodium arsenite | decreases expression | ISO | Tdrp (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of TDRP mRNA | CTD | PMID:37682722 | temozolomide | affects response to substance | ISO | TDRP (Homo sapiens) | 6480464 | TDRP mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | tetraphene | multiple interactions | ISO | Tdrp (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TDRP mRNA | CTD | PMID:27858113 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of TDRP mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TDRP mRNA | CTD | PMID:25729387 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of TDRP mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | trichostatin A results in increased expression of TDRP mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA | CTD | PMID:27188386 | triptonide | increases expression | ISO | Tdrp (Mus musculus) | 6480464 | triptonide results in increased expression of TDRP mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | Tdrp (Mus musculus) | 6480464 | troglitazone results in increased expression of TDRP mRNA | CTD | PMID:28973697 | valproic acid | increases methylation | ISO | TDRP (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of TDRP gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | TDRP (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRP mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | TDRP (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TDRP mRNA | CTD | PMID:23179753 more ... | |